SCHEMBL679526

SCHEMBL679526

COc1cc(OC)c(OC)c(OC)c1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.60
CYP3A4 P08684 1/20 0.57
MAPT P10636 1/20 0.57
CA9 Q16790 1/20 0.57
PTGS2 P35354 1/20 0.52
ATM Q13315 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
KDM4E B2RXH2 2/20 0.44
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP1B1 Q16678 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAOA P21397 1/20 0.43
POLB P06746 1/20 0.43
PTAFR P25105 2/20 0.43
TUBB4A P04350 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674233 0.83 ACHE (0.56) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL1243920 0.83 ACHE (0.56) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL30835564 0.83 ACHE (0.56) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL3356035 0.81 ACHE (0.62) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL9768502 0.81 CYP3A4 (0.58) ACHECYP3A4MAPTCA9TUBB4A
SCHEMBL21830374 0.81 ACHE (0.48) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL9348395 0.81 KDM4E (0.55) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL2150808 0.81 ACHE (0.48) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL9348470 0.81 ACHE (0.48) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL11859921 0.81 ACHE (0.48) ACHECYP3A4MAPTCA9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025070406-A1 CURABLE RESIN COMPOSITION 積水化学工業株式会社 2025-04-03 WO disclosed
WO-2024111390-A1 COMPOUND AND METHOD FOR PRODUCING SAME 学校法人帝京大学 2024-05-30 WO disclosed
EP-3247771-B1 PYRIDINES AND DERIVATIVES THEREOF AS COMPONENTS FOR USE IN OPTOELECTRONIC COMPONENTS CYNORA GMBH (DE) 2020-06-10 EP disclosed
US-10669473-B2 Organic molecules for use in optoelectronic components CYNORA GMBH (DE) 2020-06-02 US disclosed
EP-3248230-B1 USE OF ORGANIC MOLECULES IN OPTOELECTRONIC COMPONENTS CYNORA GMBH (DE) 2020-05-06 EP disclosed
US-10544361-B2 Pyridines and derivatives thereof as components for use in optoelectronic components CYNORA GMBH (DE) 2020-01-28 US disclosed
EP-3247770-B1 ORGANIC MOLECULES, IN PARTICULAR, FOR USE IN OPTOELECTRONIC COMPONENTS CYNORA GMBH (DE) 2019-04-10 EP disclosed
EP-3247768-B1 NAPHTHYL SUBSTITUTED ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC COMPONENTS CYNORA GMBH (DE) 2019-03-13 EP disclosed
CN-106414461-B Borate-based generated base alkaline agent and alkali reactive composition containing the generated base alkaline agent 富士胶片和光纯药株式会社 2018-09-11 CN disclosed
CN-106414461-A BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR 和光纯药工业株式会社 2017-02-15 CN disclosed
US-20130129832-A1 COGNITIVE IMPAIRMENT AMELIORANT TOHOKU UNIVERSITY (JP) 2013-05-23 US disclosed
US-20110287106-A1 COGNITIVE IMPAIRMENT AMELIORANT JAPAN ROYAL JELLEY CO., LTD. (JP) 2011-11-24 US disclosed
US-20110287106-A1 COGNITIVE IMPAIRMENT AMELIORANT JAPAN ROYAL JELLEY CO., LTD. (JP) 2011-11-24 US disclosed
EP-2311472-A1 COGNITIVE DISORDER-AMELIORATING AGENT Japan Royal Jelly Co., Ltd. (JP) 2011-04-20 EP disclosed
CN-101801398-A Cognitive disorder-ameliorating agent JAPAN ROYAL JELLY CO LTD 2010-08-11 CN disclosed
US-5370770-A Method for deinking printed waste paper using soybean peroxidase THE MEAD CORPORATION (US) 1994-12-06 US disclosed
US-5178762-A Water treatment for removal of organic or heavy metals THE MEAD CORPORATION (US) 1993-01-12 US disclosed
US-4900407-A Method for deoxygenation of alcohols YAMASA SHOYU KABUSHIKI KAISHA (JP) 1990-02-13 US disclosed
EP-0238672-A1 PROCESS FOR DEOXIDIZING ALCOHOL Yamasa Shoyu Kabushiki Kaisha (JP) 1987-09-30 EP disclosed
US-4229274-A PHOTOINITIATOR, PHOTOSENSITIZER, QUENCHER, AND COMPOUNDS CONTAINING ACRYLYLOXY GROUPS PPG INDUSTRIES, INC. (US) 1980-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130129832-A1 COGNITIVE IMPAIRMENT AMELIORANT CHAT, ACHE, PSEN1 ACHE 2/4885CYP3A4 4098/4885MAPT 7/4885
US-20110287106-A1 COGNITIVE IMPAIRMENT AMELIORANT CHAT, ACHE, PSEN1 ACHE 2/4885CYP3A4 4098/4885MAPT 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.